Heart Medical Europe B.V.

Back

CP Stent™

Indicated for implantation in the native and/or recurrent coarctation of the aorta on patients with the following clinical conditions:

  • Stenosis of the aorta resulting in significant anatomic narrowing as determined by angiography or noninvasive imaging, i.e. echocardiography, magnetic resonance imaging (MRI), CT scan;
  • Stenosis of the aorta resulting in hemodynamic alterations, resulting in systolic pressure gradient, systemic hypertension or altered left ventricular function;
  • Stenosis of the aorta where balloon angioplasty is ineffective or contraindicated;
  • Stenosis diameter >20% of the adjacent vessel diameter.

Covered stents are beside the above mentioned indications also indicated for:

Right Ventricular Outflow Tract (RVOT) treatment of right ventricle to pulmonary artery (right ventricular outflow tract) conduit disruptions that are identified during conduit pre-dilatation procedures performed in preparation for transcatheter pulmonary valve replacement.

The CP Stent™ is composed of 0.013” platinum/iridium wire that is arranged in a “zig” pattern that is laser welded at each joint and then over brazed with 24K gold. The 8 zig configuration allows expansion from 12 mm to 24 mm, and the 10 zig configuration allows expansion from 26 mm to 30 mm. The Covered CP Stent™ is comprised of the Bare CP Stent that is covered with an expandable sleeve of ePTFE.

  • General
  • Specifications
  • Stent Characteristics

    The CP Stent™ is composed of 0.013” platinum/iridium wire that is arranged in a “zig” pattern that is laser welded at each joint and then over brazed with 24K gold. The 8 zig configuration allows expansion from 12 mm to 24 mm, and the 10 zig configuration allows expansion from 26 mm to 30 mm. The Covered CP Stent™ is comprised of the Bare CP Stent that is covered with an expandable sleeve of ePTFE.

    Bare Stent

    Indicated for implantation in the native and/or recurrent coarctation of the aorta on patients with the following clinical conditions:

    • Stenosis of the aorta resulting in significant anatomic narrowing as determined by angiography or non-invasive imaging, i.e. echocardiography, magnetic resonance imaging (MRI), CT Scan;
    • Stenosis of the aorta resulting in hemodynamic alterations, resulting in systolic pressure gradient, systemic hypertension or altered left ventricular function;
    • Stenosis of the aorta where balloon angioplasty is ineffective or contraindicated;
    • Stenosis diameter >20% of the adjacent vessel diameter.

    Covered Stent

    Indicated for implantation in the native and/or recurrent coarctation of the aorta on patients with the following clinical conditions:

    • Stenosis of the aorta resulting in significant anatomic narrowing as determined by angiography or non-invasive imaging, i.e. echocardiography, magnetic resonance imaging (MRI), CT Scan;
    • Stenosis of the aorta resulting in hemodynamic alterations, resulting in systolic pressure gradient, systemic hypertension or altered left ventricular function;
    • Stenosis of the aorta where balloon angioplasty is ineffective or contraindicated;
    • Stenosis diameter <20% of the adjacent vessel diameter;
    • Stenosis that would present increased risk of vascular damage or disruption;
    • Aneurysm associated with coarctation of the aorta.
  • Product specifications

    CP Stent™ Specifications

    Stent
    Length
    (CM)
    Configuration
    (Number
    of Zigs)
    Platinum
    Wire
    (Inches)
    Bare
    Stent
    Catalog No.
    Covered
    Stent
    Catalog No.
    1.6 8 0.013 CP8Z16 Cvrd. CP8Z16
    2.2 8 0.013 CP8Z22 Cvrd. CP8Z22
    2.8 8 0.013 CP8Z28 Cvrd. CP8Z28
    3.4 8 0.013 CP8Z34 Cvrd. CP8Z34
    3.9 8 0.013 CP8Z39 Cvrd. CP8Z39
    4.5 8 0.013 CP8Z45 Cvrd. CP8Z45

    NuMED recommends using the BIB Stent Placement Catheter.

    CP Stent™ Foreshortening Chart 

    INFLATED
    BALLOON
    DIAMETER
    CP8Z16
    (LENGTH AFTER EXPANS.)
    (%
    shortening)
    CP8Z22
    (LENGTH AFTER EXPANS.)(%
    shortening)
    CP8Z28
    (LENGTH AFTER EXPANS.)(%
    shortening)
    CP8Z34
    (LENGTH AFTER EXPANS.)(%
    shortening)
    CP8Z39
    (LENGTH AFTER EXPANS.)(%
    shortening)
    CP8Z45
    (LENGTH AFTER EXPANS.)(%
    shortening)
    12mm 1.61cm
    (2.8%)
    2.18cm
    (0.8%)
    2.62cm
    (4.4%)
    3.23cm
    (3.1%)
    3.72cm
    (1.9%)
    4.17cm (3.8%)
    14mm 1.54cm
    (6.5%)
    2.08cm
    (5.4%)
    2.56cm
    (6.8%)
    3.15cm
    (5.4%)
    3.66cm
    (3.6%)
    3.97cm (8.4%)
    15mm 1.51cm
    (8.5%)
    2.02cm
    (7.9%)
    2.51cm
    (8.6%)
    3.10cm
    (7.0%)
    3.54cm
    (6.6%)
    3.94cm (9.2%)
    16mm 1.48cm
    (10.6%)
    1.98cm
    (10.1%)
    2.45cm
    (10.7%)
    3.00cm
    (9.8%)
    3.48cm
    (8.2%)
    3.84cm (11.4%)
    18mm 1.43cm
    (13.7%)
    1.89cm
    (14.0%)
    2.38cm
    (13.3%)
    2.88cm
    (13.5%)
    3.20cm
    (15.6%)
    3.71cm (14.5%)
    20mm 1.32cm
    (20.0%)
    1.80cm
    (17.9%)
    2.30cm
    (16.3%)
    2.63cm
    (20.9%)
    2.96cm
    (21.9%)
    3.27cm (24.7%)
    22mm 1.23cm
    (25.4%)
    1.67cm
    (23.9%)
    2.09cm
    (24.0%)
    2.46cm
    (26.0%)
    2.85cm
    (25.0%)
    3.15cm (27.3%)
    24mm 1.05cm
    (36.4%)
    1.46cm
    (33.8%)
    1.91cm
    (30.3%)
    2.07cm
    (37.9%)
    2.27cm
    (40.1%)
    2.83m (34.9%)
    BIB DELIVERY
    CATHETER
    BALLOON DIAMETER AND
    INTRODUCER SIZE
    REQUIRED INTRODUCER WITH BARE
    CP STENT
    REQUIRED INTRODUCER WITH COVERED CP STENT
    12MM (8F) 10F 12F
    14MM (8F) 10F 12F
    15MM (9F) 11F 12F
    16MM (9F) 11F 12F
    18MM (10F) 11F 14F
    20MM (10F) 12F 14F
    22MM (11F) 12F 14F
    24MM (11F) 12F 14F

    The devices listed have CE mark approval. Any customer or distributor outside of the EU will be subject to their individual country's regulations in regards to the importation and sale of these products.

    This publication could include technical or other inaccuracies or typographical errors. Changes are periodically added to the information herein; these changes will be incorporated in the new editions of the publication. NuMED Incorporated may make improvements and/or changes in the product(s) and/or the program(s) described in this publication at any time.